Market Cap | 4.65M | P/E | - | EPS this Y | - | Ern Qtrly Grth | - |
Income | -664.65k | Forward P/E | - | EPS next Y | - | 50D Avg Chg | - |
Sales | 6.9M | PEG | - | EPS past 5Y | - | 200D Avg Chg | -42.00% |
Dividend | N/A | Price/Book | EPS next 5Y | - | 52W High Chg | -83.00% | |
Recommedations | - | Quick Ratio | 0.15 | Shares Outstanding | 8.58B | 52W Low Chg | 50.00% |
Insider Own | - | ROA | -5.12% | Shares Float | - | Beta | 1.44 |
Inst Own | 0.00% | ROE | -94.33% | Shares Shorted/Prior | -/- | Price | 0.00060 |
Gross Margin | 77.90% | Profit Margin | -9.64% | Avg. Volume | 8,336,566 | Target Price | - |
Oper. Margin | -18.83% | Earnings Date | - | Volume | 680,000 | Change | 6.19% |
RushNet, Inc. provides laboratory diagnostic testing services. It offers high-complexity urine drug testing, behavioral drug testing, allergy droplet cards, oral fluids, and infectious disease services. The company is based in Jacksonville, Florida.